期刊文献+

血清尿酸、肌钙蛋白I和高敏C反应蛋白对急性冠状动脉综合征患者预后的预测价值 被引量:3

Prognostic value of serum uric acid,troponin I and high sensitive CRP in patients with acute coronary syndrome
原文传递
导出
摘要 目的:观察急性冠状动脉综合征(ACS)患者血清尿酸(UA)、肌钙蛋白I(cTnI)和高敏C反应蛋白(hs-CRP)含量并探讨对其临床预后的预测价值。方法:入选确诊ACS的住院患者592例,收集入院24h内UA、cTnI和hs-CRP的数值,并对患者出院后的心血管事件进行随访,分为心血管事件组和无心血管事件组。结果:UA、cTnI和hs-CRP在2组之间的差异均有统计学意义;校正了年龄、职业、吸烟史、BMI、高血压、糖尿病等相关因素后,血清UA、cTnI和hs-CRP能独立预测ACS患者再发心血管事件。结论:血清UA、cTnI和hs-CRP水平升高与ACS患者的再发心血管事件显著相关,具有较强的预测价值。 Objective:To investigate the level and prognostic value of serum uric acid (UA), troponin Ⅰ (cTnⅠ) and high sensitive CRP (hs-CRP) in patients with acute coronary syndrome (ACS). Method:A total of 592 patients with ACS was enrolled in this study. Blood samples were collected within 24 hours after admission for the determination of serum UA, cTnⅠ and hs-CRP. The post discharge cardiovascular events were recorded by which the patients were divided into cardiovascular events group and non-cardiovascular events group. Result: Serum UA, cTnⅠ, and hs-CRP levels were significantly different between two groups. After adjusting the related factors including age, vocation, smoking history, BMI, hypertension, diabetes in logistic regression, serum UA, cTnⅠ and hs- CRP levels had independent predictive values for post discharge cardiovascular events. Conclusion:The levels of serum UA, cTnⅠ and hs-CRP, as prognostic factors, are closely associated with post-discharge cardiovaseular events in patients with ACS.
出处 《临床心血管病杂志》 CSCD 北大核心 2008年第9期665-667,共3页 Journal of Clinical Cardiology
关键词 冠状动脉综合征 预后 尿酸 肌钙蛋白Ⅰ 高敏C反应蛋白 Acute coronary syndrome Prognosis Uric acid Troponin Ⅰ, High-sensitive C reactive protein
  • 相关文献

参考文献13

  • 1FICHTLSCHERER S, HEESCHEN C, ZEIHER A. Inflammatory markers and coronary heart disease[J]. Curr Opin Pharmacol, 2004,4 : 124-131.
  • 2PAUL M, RIDKER M D. High-sensitivity C-reactive protein and cardiovascular risk:rationale for screening and primary prevention[J]. Am J Cardiol,2003,92 : 17--22.
  • 3GIL M, ZAREBINSKE M, ADAMUS J, et al. Plasma fibrinogen and troponin I in acute coronary syn drome and stable angina[J]. Int J Cardiol, 2002,83: 43--46.
  • 4BOLIBAR I, VON ECKARDSTEIN A, ASSMANN G, et al. Short-term prognostic value of lipid measurements in patients with angina peetoris[J]. Thromb Haemost, 2000,84:955--960.
  • 5BICKEL C, RUPPRECHT H J, LANKENBERG B, et al. Relation of markers of inflammation (CRP, vWF, fibrinogen and leukocyte count) and statin therapy to long-time mortality in patients with anglographically proven CHD[J]. Am J Cardiol, 2002,89 : 901--908.
  • 6FICHTLSCHERER S, HEESCHEN C, ZEIHER A M. Inflammatory markers and coronary heart disease [J]. Curr Opin Pharmacol, 2004, 4:124--131.
  • 7姜立清,赵明中,胡大一.肌钙蛋白I对非ST段抬高急性冠状动脉综合征临床转归的预测价值[J].中华内科杂志,2005,44(5):350-352. 被引量:14
  • 8WANNAMETHEE S G, SHAPER A G, WHINCUP P H. Serum urate and the risk of major coronary heart disease events[J]. Heart, 1997,78 : 147-- 153.
  • 9王东方.急性冠状动脉综合征患者血清尿酸水平的变化[J].中国循环杂志,2004,19(1):49-49. 被引量:16
  • 10CHRISTOPH B, HANS J R, STEFAN B, et al. Serum uric acid as an independent predictor of mortality in patients with angiographically proven cornonary disease[J]. Am J Cardiol, 2002, 89:12--12.

二级参考文献19

  • 1熊全庚,范木林,郭跃华.早期强化辛伐他汀治疗急性冠状动脉综合征的研究[J].临床心血管病杂志,2004,20(12):710-712. 被引量:25
  • 2Falk E. Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. Circulation, 1985,71:699-708.
  • 3Davies MJ, Thomas AC, Knapman PA, et al. Intramyocardial platelet aggregation in patients with unstable angina suffering sudden ischemic cardiac death. Circulation, 1986,73:418-427.
  • 4Gotlieb AI, Freeman MR, Salerno TA,et al. Ultrastructural studies of unstable angina in living man. Mod Pathol,1991,4:75-80.
  • 5Lindahl B, Venge P, Wallentin L. Troponin T identifies patients with unstable coronary artery disease who benefit from long-term antithrombotic protection. Fragmin in Unstable Coronary Artery Disease (FRISC) Study Group. J Am Coll Cardiol, 1997,29:43-48.
  • 6Morrow DA, Antman EM, Tanasijevic M, et al. Cardiac troponin I for stratification of early outcomes and the efficacy of enoxaparin in unstable angina: a TIMI-11B substudy. J Am Coll Cardiol,2000,36:1812-1817.
  • 7KINLAY S, SELWYN A P, DELAGRANGE D, et al. Biological mechanisms for the clinical success of lipid-lowering in coronary artery disease and the use ofsurrogate end points [J]. Curr Opin Lipidol, 1996,7:389-397.
  • 8ALBEROLA AGUILAR A M, REVERT F, MOYA A, et al. Intravenous BQ-123 and phosphoramidon reduce ventricular ectopic beats and myocardial infarct size in dogs submitted to coronary occlusion and reperfusion[J]. Gen Pharmacol, 2000, 35 : 143- 147.
  • 9TRACY R P, LEMSITRE R N, PSATY B M, et al.Relationship of C-reactive protein to risk of cardiovascular disease in the elderly: results from the cardiovascular health study and the real health promotion project [J]. Arterioscler Thromb Vase Biol, 1997,17:1121-1126.
  • 10WATERS D D, AZAR R R. Should intensive cholesterol lowering play a role in the management of acute coronary syndromes [J]. Am J Cardiol, 2000, 86(8B): 35J-42J.

共引文献59

同被引文献31

  • 1冯缨缨,孙宜萍,王蓓芸,崔亮,梁瑞廉.高血压病伴高尿酸血症与冠心病发生的关系分析[J].中国医师杂志,2005,7(8):1092-1093. 被引量:9
  • 2芦涤,郭乐凌,周琪.非ST段抬高急性冠状动脉综合征患者早期介入治疗前应用替罗非班近期预后的临床观察[J].中国综合临床,2007,23(10):865-867. 被引量:2
  • 3Abbate R, Cioni G, Ricci II, et al. Thrombosis and acute coronary syndrome [ J ]. Thromb Res, 2012,129 ( 3 ) :235-240.
  • 4Morrow DA, Delemons JA, Sabatine MS, et al. Evaluation of B- type natriuretic peptide for risk assessment in unstable angina non- ST-elevation myocardial infarction; B-type natriuretic peptide and prognosis in TACTICS TIMI 18[J]. J Am coil cardiol, 2003,41 (8) :1264-1272.
  • 5Kim SY, Gvevara JP, Kim KY, et al. Hyperurieemia and coronary heart disease: a systematic review and meta-analysis [ J ]. Arthritis Care Res (Hobken) , 2010,62(2) : 170-180.
  • 6Gopal D J, Iqbal MN, Maisel A. Updating the role of natriuretie peptide levels in cardiovascular disease [ J ]. Postgrad Med, 2011, 123(6) :102-113.
  • 7Meune C, Martins E, Fulla Y, et al. New biological markers for ae- nte eoronary artery disease [ J ]. J Mal Vase, 2003,28 ( 5 ) :251-257.
  • 8Christopher H, Christian W, Veselin M, et al. N-terminal pro-B- type natriuretie prptide levels for dynamic risk stratification of pa- tients with deute coronary syndromes [ J ]. Circulation, 2004,110 ( 20 ) : 3206 -3212.
  • 9Talwar S, Squire LB, Downie PF, et al. Plasma N terminal prob- brain n atriuretic peptide and Cardiotrophin 1 are raised in unstable angina [ J ]. Heart, 2000,84 (4) :422--424.
  • 10Eggers KM, Lagerqvist B, Venge P, et al. prognostic value of bio- markers during and ofter non-ST-segment elevation acu coronary syndrome[J]. Am coil cardiol, 2009,54(4) :357-364.

引证文献3

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部